Annual jab for HIV protection passes trial hurdle
Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.
hello@uk4mag.co.uk
0
25
Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.
/cloudfront-us-east-1.images.arcpublishing.com/gray/KFIET7ZYIFEURJHJSR4D5ZDPDQ.jpg){kind=small}
